These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24889897)

  • 1. Antagonizing STAT3 dimerization with a rhodium(III) complex.
    Ma DL; Liu LJ; Leung KH; Chen YT; Zhong HJ; Chan DS; Wang HM; Leung CH
    Angew Chem Int Ed Engl; 2014 Aug; 53(35):9178-82. PubMed ID: 24889897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group 9 organometallic compounds for therapeutic and bioanalytical applications.
    Ma DL; Chan DS; Leung CH
    Acc Chem Res; 2014 Dec; 47(12):3614-31. PubMed ID: 25369127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
    Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR
    J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel non-phosphorylated potential antitumoral peptide inhibits STAT3 biological activity.
    Dourlat J; Liu WQ; Sancier F; Edmonds T; Pamonsinlapatham P; Cruzalegui F; Garbay C
    Biochimie; 2009 Aug; 91(8):996-1002. PubMed ID: 19470402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of ferrocene appended Ru(II), Rh(III) and Ir(III) dipyrrinato complexes with DNA/protein, molecular docking and antitumor activity.
    Paitandi RP; Gupta RK; Singh RS; Sharma G; Koch B; Pandey DS
    Eur J Med Chem; 2014 Sep; 84():17-29. PubMed ID: 25014746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rhodium(III)-based inhibitor of autotaxin with antiproliferative activity.
    Kang TS; Wang W; Zhong HJ; Liang JX; Ko CN; Lu JJ; Chen XP; Ma DL; Leung CH
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):256-263. PubMed ID: 27888146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of zwitterionic half-sandwich Rhodium(III) and Ruthenium(II) organometallic complexes.
    Guo L; Hu X; Yang Y; An W; Gao J; Liu Q; Liu Z
    Bioorg Chem; 2021 Nov; 116():105311. PubMed ID: 34474302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved antiparasitic activity by incorporation of organosilane entities into half-sandwich ruthenium(II) and rhodium(III) thiosemicarbazone complexes.
    Adams M; de Kock C; Smith PJ; Land KM; Liu N; Hopper M; Hsiao A; Burgoyne AR; Stringer T; Meyer M; Wiesner L; Chibale K; Smith GS
    Dalton Trans; 2015 Feb; 44(5):2456-68. PubMed ID: 25559246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design.
    Yu W; Xiao H; Lin J; Li C
    J Med Chem; 2013 Jun; 56(11):4402-12. PubMed ID: 23651330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhodium, iridium, and ruthenium half-sandwich picolinamide complexes as anticancer agents.
    Almodares Z; Lucas SJ; Crossley BD; Basri AM; Pask CM; Hebden AJ; Phillips RM; McGowan PC
    Inorg Chem; 2014 Jan; 53(2):727-36. PubMed ID: 24397747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermally inert metal ammines as light-inducible DNA-targeted agents. Synthesis, photochemistry, and photobiology of a prototypical rhodium(III)-intercalator conjugate.
    Barry CG; Turney EC; Day CS; Saluta G; Kucera GL; Bierbach U
    Inorg Chem; 2002 Dec; 41(26):7159-69. PubMed ID: 12495358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrochemical detection of the Fc-STAT3 phosphorylation and STAT3-Fc-STAT3 dimerization and inhibition.
    Martic S; Rains MK; Haftchenary S; Shahani VM; Kraskouskaya D; Ball DP; Gunning PT; Kraatz HB
    Mol Biosyst; 2014 Mar; 10(3):576-80. PubMed ID: 24402062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
    Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
    Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer activity of cyclic amine and thiaether metal complexes.
    Medvetz DA; Stakleff KD; Schreiber T; Custer PD; Hindi K; Panzner MJ; Blanco DD; Taschner MJ; Tessier CA; Youngs WJ
    J Med Chem; 2007 Apr; 50(7):1703-6. PubMed ID: 17343369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of a novel oral signal transducer and activator of transcription 3 inhibitor YHO-1701.
    Nishisaka F; Taniguchi K; Tsugane M; Hirata G; Takagi A; Asakawa N; Kurita A; Takahashi H; Ogo N; Shishido Y; Asai A
    Cancer Sci; 2020 May; 111(5):1774-1784. PubMed ID: 32112605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhodium(II) Proximity-Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti-Leukemia Activity.
    Minus MB; Liu W; Vohidov F; Kasembeli MM; Long X; Krueger MJ; Stevens A; Kolosov MI; Tweardy DJ; Sison EA; Redell MS; Ball ZT
    Angew Chem Int Ed Engl; 2015 Oct; 54(44):13085-9. PubMed ID: 26480340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of new polynuclear organometallic Ru(II), Rh(III) and Ir(III) pyridyl ester complexes as in vitro antiparasitic and antitumor agents.
    Chellan P; Land KM; Shokar A; Au A; An SH; Taylor D; Smith PJ; Riedel T; Dyson PJ; Chibale K; Smith GS
    Dalton Trans; 2014 Jan; 43(2):513-26. PubMed ID: 24121555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of luminescent biotinylation reagents derived from cyclometalated iridium(III) and rhodium(III) bis(pyridylbenzaldehyde) complexes.
    Leung SK; Kwok KY; Zhang KY; Lo KK
    Inorg Chem; 2010 Jun; 49(11):4984-95. PubMed ID: 20465281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing anti-cancer activity with longer tether lengths of group 9 Cp* complexes.
    Lucas SJ; Lord RM; Basri AM; Allison SJ; Phillips RM; Blacker AJ; McGowan PC
    Dalton Trans; 2016 Apr; 45(16):6812-5. PubMed ID: 26924272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents.
    Lucas SJ; Lord RM; Wilson RL; Phillips RM; Sridharan V; McGowan PC
    Dalton Trans; 2012 Dec; 41(45):13800-2. PubMed ID: 23015068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.